Study on multimode rehabilitation of patients with malignant tumor

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200055349

Enrollment

Unknown

Registered

2022-01-07

Start date

2021-10-01

Completion date

Unknown

Last updated

2023-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

malignant tumor

Interventions

treatment group:Whole-process multi-mode rehabilitation management

control group:Standard treatment

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Voluntarily participate and sign the informed consent in writing; 2. Gender is not limited; 3. Malignant tumors diagnosed by pathology and/or cytology before enrollment; 4. Expected survival period >= 3 months; 5. General physical condition (ECOG) 0-2; 6. Normal heart and lung function; 7. Have reading comprehension ability and be able to complete the questionnaire.

Exclusion criteria

Exclusion criteria: 1. Neurological or psychiatric abnormalities affecting cognitive ability, including central nervous system transfer; 2. Uncontrolled systemic diseases, such as poorly controlled diabetes.

Design outcomes

Primary

Measure	Time frame
Nutrition assessment;Physical function assessment;	—

Secondary

Measure	Time frame
Psychological assessment;	—

Countries

China

Contacts

Public ContactLi Zengning

The First Hospital of Hebei Medical University

lizengning@126.com+86 18633889888

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026